Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering high yields and simplified supply chains for pharmaceutical manufacturing.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN112961086A introduces a novel rhodium-catalyzed one-step synthesis method for high-purity pharmaceutical intermediates with significant cost reduction potential through streamlined manufacturing processes.
Patent CN115286578B enables room-temperature metal-free production of trifluoromethyl pyrazole compounds, delivering substantial cost reduction and enhanced supply chain reliability for pharmaceutical intermediates.
Novel metal-free synthesis enables high stereoselectivity and scalable production of fluorinated intermediates offering cost reduction and reliable supply for pharmaceutical manufacturing.
Patent CN116253692A enables metal-free synthesis of trifluoromethyl triazine intermediates at room temperature, delivering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.
Innovative rare earth metal cluster catalysis enables solvent-free amide synthesis with high yields and broad substrate scope enhancing supply chain reliability for pharmaceutical intermediates
Patent CN115286578B enables high-purity trifluoromethyl pyrazole intermediates through room temperature metal-free catalysis, reducing manufacturing costs and ensuring reliable pharmaceutical supply chains.
Patent CN110467579B enables heavy metal-free synthesis of high-purity triazoles with streamlined manufacturing and reliable supply chain benefits.
Patent CN115286578B enables metal-free production of high-purity pyrazole intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN105152826B enables high-purity biphenyl intermediates with >96% yield, reducing manufacturing costs and lead times for pharmaceutical supply chains.
Metal-free synthesis of 5-trifluoromethyl triazole compounds enables scalable production with high purity and reduced manufacturing costs for pharmaceutical applications.
Patent CN118126005B enables metal-free synthesis of high-purity dihydrobenzofuran intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN116253692A enables metal-free triazine synthesis at room temperature, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.
Discover how glucose-based synthesis of 3-trifluoromethyl-1,2,4-triazole eliminates anhydrous/oxygen-free requirements, cuts production costs, and ensures 99% purity for pharmaceutical intermediates.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.
Solve high-cost N-difluoromethylation challenges with this room-temperature, metal-free method. 90% yields, broad substrate tolerance, and no special equipment needed. Scale to 100 MT/yr.
Solve 5-trifluoromethyl imidazole synthesis challenges with our CDMO's scalable, high-yield process. Reduce costs by 30% and ensure supply chain stability for your API development.
Discover metal-free β-iodonitroalkene synthesis with 80%+ yields. Eliminate oxidant risks & simplify GMP production for API intermediates.